Rocket Lab's Backlog Soars Past $2 Billion, but the Profit Question Lingers

Rocket Lab's Q2 2026 shows 62% revenue growth and $2.36B backlog, but a $49.3M net loss and Neutron delay pressure the stock.

Rocket Lab's second-quarter scorecard reads like a study in contradictions: revenue climbing at a 62 percent clip, a contract pipeline swelling to $2.36 billion, and yet the bottom line still bleeding red. For a company that has spent the past year positioning itself as the scrappy challenger to the old space guard, the numbers tell two competing stories — one of momentum, the other of margin.

The Q2 2026 figures landed with a thud on the earnings front. The company posted a net loss of $49.3 million, translating to a per-share loss of $0.08, a miss against the $0.06 analysts had penciled in. That gap between top-line strength and bottom-line weakness has become the central tension animating the stock's recent slide, which has now reached roughly 18 percent below its 50-day moving average.

A Flurry of Contracts That Wall Street Is Struggling to Cheer

The order book, however, tells a decidedly more upbeat story. Rocket Lab's backlog has ballooned 137 percent year over year, fueled by a remarkable run of contract announcements in recent weeks. The US Space Force has emerged as a particularly active patron, with a $397 million award for the Space-Based Airborne Moving Target Indicator program and a separate $981 million initiative dubbed NITE-STAR. A $12 million contract under the Space Data Network Consortium adds to the government pipeline, alongside a partnership with Viasat to develop a maneuverable, jamming-resistant satellite system.

The Space Data Network selection carries strategic weight beyond its dollar figure. Rocket Lab now sits alongside Amazon LEO for Government, Lockheed Martin, Northrop Grumman and York Space Systems in building out a multi-vendor space data network — a clear signal that the company has earned a seat at the defense table. The unveiling of GHOST, a portable launch architecture designed to enable "anytime, anywhere" launch capability for Electron and HASTE, reinforces that military posture.

Commercial momentum hasn't lagged either. The 93rd Electron mission on August 20 delivered an Earth-observation satellite for Japanese client iQPS — the ninth such satellite Rocket Lab has placed for that customer — marking the company's 14th successful launch of the year with a perfect success rate. Meanwhile, eight satellite platforms built for MDA Space have reached orbit, supporting Globalstar's direct-to-device communications services. That work is part of a 17-platform order valued at $143 million.

The Neutron Question and a Pivotal Acquisition

Yet none of this operational cadence has quieted the market's biggest worry: the delayed first flight of the Neutron rocket. The postponement, disclosed roughly two weeks ago, has weighed on the share price, with the stock off about 17.4 percent since the announcement. Development work continues apace — the company is currently testing the reusable fairing nicknamed "Hungry Hippo," running flight-like opening and closing trials before integrating the component with Neutron's interstage — but the absence of a firm launch date keeps a cloud over the narrative.

The more consequential strategic development may be unfolding on the mergers and acquisitions front. Rocket Lab's proposed takeover of Iridium Communications cleared its US antitrust waiting period on August 12, and the company has since filed its S-4 registration statement with the SEC. A successful integration would transform Rocket Lab from a launch provider into an operator of its own satellite infrastructure with recurring revenue streams — a shift that would fundamentally alter how investors value the business.

Reading the Insider Sales

The stock sales by CEO Peter Beck and General Counsel Arjun Kampani over the past six months might raise eyebrows at first glance. But those transactions typically run through pre-arranged trading plans established well in advance, executed on fixed schedules for tax planning and portfolio diversification rather than in response to market conditions. Reading them as a lack of management conviction would be a stretch.

A more telling signal may come from the other side of the trade: Cathie Wood's ARK Investment added 161,000 shares during the same period, a vote of confidence from one of the market's most prominent growth investors.

Guidance Points to a Gradual Path

The third-quarter outlook suggests incremental progress rather than a breakthrough. Management projects revenue between $250 million and $265 million, with non-GAAP gross margin improving to 35 to 37 percent. The adjusted EBITDA loss of $17 million to $23 million, however, makes clear that profitability remains a work in progress.

For now, Rocket Lab finds itself in an unusual position: a company whose operational achievements are difficult to dispute, but whose share price keeps reflecting the distance between ambition and earnings. The backlog, the defense contracts and the Iridium timeline all point toward structural growth. Whether investors have the patience to wait for the profit proof is another matter entirely.